Cargando…

Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone

Previous studies have demonstrated that the bone targeting agent BT2-peg2 (BT2-minipeg2, 9), when conjugated to vancomycin and delivered systemically by intravenous (IV) or intraperitoneal (IP) injection accumulates in bone to a greater degree than vancomycin alone, but that this accumulation is ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albayati, Zaineb A.F., Penthala, Narsimha R., Bommagani, Shobanbabu, Post, Ginell R., Smeltzer, Mark S., Crooks, Peter A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898066/ https://www.ncbi.nlm.nih.gov/pubmed/33665133 http://dx.doi.org/10.1016/j.toxrep.2021.02.002

Ejemplares similares

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

(E)-13-(2-Bromophenyl)micheliolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Crystal structure of (E)-13-{4-[(Z)-2-cyano-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl}parthenolide methanol hemisolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Comparison of crystal structures of 4-(benzo[b]thiophen-2-yl)-5-(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole and 4-(benzo[b]thiophen-2-yl)-2-methyl-5-(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Crystal structure of 4,5-bis(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole methanol monosolvate
por: Madadi, Nikhil Reddy, et al.
Publicado: (2014)

13-(N,N-Dimethylamino)micheliolide 0.08-hydrate
por: Bommagani, Shobanbabu, et al.
Publicado: (2013)

Crystal structure of 13-(E)-(2-aminobenzylidene)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2018)

Oxone(®)-Mediated TEMPO-Oxidized Cellulose Nanomaterials form I and form II
por: Moore II, John P, et al.
Publicado: (2020)

(Z)-3-(1-Benzofuran-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

(Z)-3-(1H-Indol-3-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

rac-5-Bromo-N-benzylisatincreatinine ethanol monosolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

rac-N-Benzylisatincreatinine (unknown solvate)
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

rac-2-(2-Amino-4-oxo-4,5-dihydro-1,3-thiazol-5-yl)-2-hydroxyindane-1,3-dione
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-3-hydroxyindolin-2-one monohydrate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

(2Z,3E)-2-{[1-(4-Chlorobenzyl)-1H-indol-3-yl]methylidene}quinuclidin-3-one oxime
por: Penthala, Narsimha Reddy, et al.
Publicado: (2011)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-3-hydroxy-1-phenylindolin-2-one ethanol solvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-5-fluoro-3-hydroxy-1-methylindolin-2-one methanol hemisolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

rac-(Z)-Methyl 1-benzyl-3-[(3-hydroxyquinuclidin-2-ylidene)methyl]-1H-indole-6-carboxylate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

Evaluation of morphine‐like effects of the mixed mu/delta agonist morphine‐6‐O‐sulfate in rats: Drug discrimination and physical dependence
por: Yadlapalli, Jai Shankar K., et al.
Publicado: (2018)

Crystal structures of (Z)-5-[2-(benzo[b]thiophen-2-yl)-1-(3,5-dimethoxyphenyl)ethenyl]-1H-tetrazole and (Z)-5-[2-(benzo[b]thiophen-3-yl)-1-(3,4,5-trimethoxyphenyl)ethenyl]-1H-tetrazole
por: Penthala, Narsimha Reddy, et al.
Publicado: (2016)

cis-2,5-Bis(2-fluoro-5-methoxyphenethyl)pyrrolidinium formate
por: Ponugoti, Purushothama Rao, et al.
Publicado: (2011)

(Z)-4-[3-(2,5-Dioxoimidazolidin-4-ylidenemethyl)-1H-indol-1-ylmethyl]benzonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2008)

(Z)-Methyl 4-[3-(3-oxoquinuclidin-2-ylidenemethyl)-1H-indol-1-ylmethyl]benzoate
por: Reddy, Thirupathi Reddy Yerram, et al.
Publicado: (2008)

(Z)-4-[3-(3-Oxoquinuclidin-2-ylidenemethyl)-1H-indol-1-ylmethyl]benzonitrile
por: Reddy, Thirupathi Reddy Yerram, et al.
Publicado: (2008)

cis-1-Benzylpyrrolidine-2,5-dicarbonitrile
por: Ponugoti, Purushothama Rao, et al.
Publicado: (2011)

(Z)-Methyl 4-({3-[(2,5-dioxoimidazolidin-4-ylidene)methyl]-1H-indol-1-yl}methyl)benzoate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2008)

(E,E)-1-Methyl-2,6-distyrylpyridinium iodide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2010)

Comparison of the crystal structures of 4,4′-bis[3-(4-methylpiperidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl and 4,4′-bis[3-(2,2,6,6-tetramethylpiperidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl
por: Wan, Anqi, et al.
Publicado: (2015)

13-(Imidazol-1-yl)-11,13-dihydromelampomagnolide B monohydrate
por: Janganati, Venumadhav, et al.
Publicado: (2013)

(Z)-2-Amino-5-[2,4-dimethoxy-6-(4-methoxystyryl)benzylidene]-1,3-thiazol-4(5H)-one methanol solvate
por: Madadi, Nikhil Reddy, et al.
Publicado: (2010)

Comparison crystal structure conformations of two structurally related biphenyl analogues: 4,4′-bis[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl and 4,4′-bis{3-[(S)-2-methylpyrrolidin-1-yl]prop-1-yn-1-yl}-1,1′-biphenyl
por: Wan, Anqi, et al.
Publicado: (2015)

A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer’s Disease
por: Kakraba, Samuel, et al.
Publicado: (2019)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Monosuccinate ester of melampomagnolide B
por: Janganati, Venumadhav, et al.
Publicado: (2014)

In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
por: Zong, Hongliang, et al.
Publicado: (2015)

BT2 Suppresses Human Monocytic-Endothelial Cell Adhesion, Bone Erosion and Inflammation
por: Yeh, Mei-Chun, et al.
Publicado: (2021)

Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)

Competitive trampolining influences trabecular bone structure, bone size, and bone strength
por: Burt, Lauren A., et al.
Publicado: (2016)

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
por: Kadouri, L, et al.
Publicado: (2001)

The Toll-Like Receptor 2 agonist PEG-Pam(2)Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
por: Ernest, Medard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_epb724iu0qknbs4s4d7arbimck